NCT01602835View on ClinicalTrials.gov

Human Urine Sample Collection for Alport Nephropathy Biomarker Studies

TerminatedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Alport Syndrome
Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT01602835 - Human Urine Sample Collection for Alport Nephropathy Biomarker Studies | Biotech Hunter | Biotech Hunter